These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25150263)

  • 1. [Pharmacokinetics and pharmacodynamics of antibiotic therapy].
    Beck S; Wicha SG; Kloft C; Kees MG
    Anaesthesist; 2014 Oct; 63(10):775-82. PubMed ID: 25150263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a dosing algorithm for meropenem in critically ill patients based on a population pharmacokinetic/pharmacodynamic analysis.
    Ehmann L; Zoller M; Minichmayr IK; Scharf C; Huisinga W; Zander J; Kloft C
    Int J Antimicrob Agents; 2019 Sep; 54(3):309-317. PubMed ID: 31229669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using PK/PD to optimize antibiotic dosing for critically ill patients.
    Roberts JA
    Curr Pharm Biotechnol; 2011 Dec; 12(12):2070-9. PubMed ID: 21554211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections.
    Tängdén T; Ramos Martín V; Felton TW; Nielsen EI; Marchand S; Brüggemann RJ; Bulitta JB; Bassetti M; Theuretzbacher U; Tsuji BT; Wareham DW; Friberg LE; De Waele JJ; Tam VH; Roberts JA;
    Intensive Care Med; 2017 Jul; 43(7):1021-1032. PubMed ID: 28409203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combatting the Rising Tide of Antimicrobial Resistance: Pharmacokinetic/Pharmacodynamic Dosing Strategies for Maximal Precision.
    Chua HC; Tse A; Smith NM; Mergenhagen KA; Cha R; Tsuji BT
    Int J Antimicrob Agents; 2021 Mar; 57(3):106269. PubMed ID: 33358761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of antibiotic pharmacokinetic principles in the critically ill.
    Udy AA; Roberts JA; Lipman J
    Intensive Care Med; 2013 Dec; 39(12):2070-82. PubMed ID: 24045886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimisation of antimicrobial dosing based on pharmacokinetic and pharmacodynamic principles.
    Hoo GSR; Liew YX; Kwa AL
    Indian J Med Microbiol; 2017; 35(3):340-346. PubMed ID: 29063877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions.
    Roberts JA; Abdul-Aziz MH; Lipman J; Mouton JW; Vinks AA; Felton TW; Hope WW; Farkas A; Neely MN; Schentag JJ; Drusano G; Frey OR; Theuretzbacher U; Kuti JL;
    Lancet Infect Dis; 2014 Jun; 14(6):498-509. PubMed ID: 24768475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis.
    Abdul-Aziz MH; Sulaiman H; Mat-Nor MB; Rai V; Wong KK; Hasan MS; Abd Rahman AN; Jamal JA; Wallis SC; Lipman J; Staatz CE; Roberts JA
    Intensive Care Med; 2016 Oct; 42(10):1535-1545. PubMed ID: 26754759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development.
    Abdul-Aziz MH; Lipman J; Mouton JW; Hope WW; Roberts JA
    Semin Respir Crit Care Med; 2015 Feb; 36(1):136-53. PubMed ID: 25643277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Right dose, right now: using big data to optimize antibiotic dosing in the critically ill.
    Elbers PW; Girbes A; Malbrain ML; Bosman R
    Anaesthesiol Intensive Ther; 2015; 47(5):457-63. PubMed ID: 26459228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumannii.
    Luque S; Grau S; Valle M; Sorlí L; Horcajada JP; Segura C; Alvarez-Lerma F
    Int J Antimicrob Agents; 2013 Aug; 42(2):178-81. PubMed ID: 23769664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and Pharmacodynamics of Extended-Infusion Cefepime in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Prospective, Open-Label Study.
    Philpott CD; Droege CA; Droege ME; Healy DP; Courter JD; Ernst NE; Harger NJ; Foertsch MJ; Winter JB; Carter KE; Van Fleet SL; Athota K; Mueller EW
    Pharmacotherapy; 2019 Nov; 39(11):1066-1076. PubMed ID: 31549737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose optimisation of antibiotics in children: application of pharmacokinetics/pharmacodynamics in paediatrics.
    Downes KJ; Hahn A; Wiles J; Courter JD; Vinks AA
    Int J Antimicrob Agents; 2014 Mar; 43(3):223-30. PubMed ID: 24389079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients.
    Ulldemolins M; Roberts JA; Rello J; Paterson DL; Lipman J
    Clin Pharmacokinet; 2011 Feb; 50(2):99-110. PubMed ID: 21142293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Personalised antibiotic therapy in a surgical intensive care unit overview of current knowledge and the results of an observational kinetic study].
    Kaška M; Martinková J; Havel E; Kočí J; Fousková A; Solichová D; Kujovská L; Selke-Krulichová I; Práznovec I; Salavec V
    Rozhl Chir; 2014 Sep; 93(9):456-62. PubMed ID: 25301344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adequate anti-infective treatment : Importance of individual dosing and application].
    Brinkmann A; Röhr AC; Köberer A; Fuchs T; Krüger WA; König C; Richter D; Weigand MA; Frey OR
    Anaesthesist; 2018 Jun; 67(6):461-476. PubMed ID: 29766208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of the pharmacokinetic/pharmacodynamic (PK/PD) analysis of antimicrobial agents.
    Asín-Prieto E; Rodríguez-Gascón A; Isla A
    J Infect Chemother; 2015 May; 21(5):319-29. PubMed ID: 25737147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards precision medicine: Therapeutic drug monitoring-guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity.
    Cusumano JA; Klinker KP; Huttner A; Luther MK; Roberts JA; LaPlante KL
    Am J Health Syst Pharm; 2020 Jul; 77(14):1104-1112. PubMed ID: 32537644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of extended-interval aminoglycoside dosing strategies for the treatment of moderate-to-severe infections encountered in critically ill surgical patients.
    Mueller EW; Boucher BA
    Surg Infect (Larchmt); 2009 Dec; 10(6):563-70. PubMed ID: 20035611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.